CYC-065 Uses, Dosage, Side Effects and more
CYC-065 is under investigation in clinical trial NCT03739554 (CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL).
| Trade Name | CYC-065 |
| Generic | CYC-065 |
| Type | |
| Formula | C21H31N7O |
| Weight | Average: 397.527 Monoisotopic: 397.259008646 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
